Skip to content
2000
Volume 18, Issue 2
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy, even though LVEF is a better marker of total mortality than ventricular tachyarrhythmias mortality. This review evaluates imaging tools and novel biomarkers proposed for better risk stratifying arrhythmic substrate, thereby identifying optimal ICD therapy candidates.

Loading

Article metrics loading...

/content/journals/ccr/10.2174/1573403X17666210804125939
2022-03-01
2025-06-16
Loading full text...

Full text loading...

/content/journals/ccr/10.2174/1573403X17666210804125939
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test